Israeli medical cannabis firm InterCure plans Nasdaq listing: Reuters

Israel’s InterCure (INCR.TA), which recently entered the medical cannabis market, plans to list on Nasdaq by mid-2019, its controlling shareholder, Alex Rabinovitch, said on Thursday.